(123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease

OBJECTIVES—(123)I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy is clinically used to estimate local myocardial sympathetic nerve damage in some forms of heart disease, autonomic nerve disturbance in diabetic neuropathy, and disturbance of the autonomic nervous system in neurodegenerative d...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Orimo, S, Ozawa, E, Nakade, S, Sugimoto, T, Mizusawa, H
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Group 1999
Assuntos:
Papers
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1736461/
https://ncbi.nlm.nih.gov/pubmed/10406987
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares